# Shanghai Hengrui Pharmaceutical Co., Ltd. – FDA Inspection, Jul 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/shanghai-hengrui-pharmaceutical-co-ltd/9fe79127-f71d-4a2b-9745-b9653a8fb43d
Source feed: FDA_Inspections

> FDA inspection 1063523 of Shanghai Hengrui Pharmaceutical Co., Ltd., July 20, 2018. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1063523
- Company Name: Shanghai Hengrui Pharmaceutical Co., Ltd.
- Inspection Date: 2018-07-20
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1252840 - 2024-10-25](https://www.keypedia.com/records/fda_inspections/shanghai-hengrui-pharmaceutical-co-ltd/71e9f880-30b1-40c7-9e66-32ce9105e679)
- FDA Inspection 921475 - 2015-03-27
- FDA Inspection 850208 - 2013-09-06

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/helen-verdel/f6caf5a8-74f5-4833-bd00-5579b369f4f9)

Company: https://www.keypedia.com/companies/shanghai-hengrui-pharmaceutical-co-ltd/fea82b47-cc0a-45cf-aaf2-0cab64dcd8ef

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c